MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disorder characterised by the accumulation of extracellular amyloid-beta (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau [1].